UgenTec, the Belgian PCR automation software company and Hamann Laborautomation today announced their partnership venture into the PCR middleware land...

Founded in 2009 in Sydney, SpeeDx’ current IVD portfolio consists of two multiplex assays: ResistancePlus™ MG and PlexPCR™HSV-1&2, VZV. The company i...

UgenTec & PathoFinder have successfully rolled out the interpretation solution for PathoFinder’s next generation multiplex PCR 2SMART assays.

UgenTec NV, the European bio-informatics company that develops artificially intelligent PCR interpretation software, and SpeeDx Pty. Ltd., a developer...

UgenTec, the Belgian company that is developing independent PCR analysis software based on artificial intelligence and machine learning, closed a €2.1...

UgenTec has been nominated for the 2016 Rising Star award, together with nine other innovative and rapid growing companies. The Rising Star selection ...

We're happy to announce that Unizo, the organization that represents employers and entrepreneurs in Flanders, has elected UgenTec to be the "Most Prom...

We are proud to announce that we have received more than €1M in venture capital funding from a group of Belgian investors and an additional €250 000 i...

We are proud to announce that we've won the “Flanders Future” award. The award is handed to companies that are deemed the most capable of achieving in...

UgenTec’s FastFinder has won the “Healthcare idea award 2014” for the most innovative product in healthcare. The software, developed by UgenTec, allow...